C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2011
10/13/2011	WO2011125029A1 THERAPEUTIC USE OF THE ß2m PROTEIN
10/13/2011	WO2011125028A1 Assay for phytol-free chlorophyll derivatives
10/13/2011	WO2011124927A1 Method of analysing a cell or other biological material containing a nucleic acid
10/13/2011	WO2011124884A2 Methods
10/13/2011	WO2011124869A1 Self-assembling half-antibodies
10/13/2011	WO2011124758A1 A method, an arrangement and a computer program product for analysing a cancer tissue
10/13/2011	WO2011124725A1 Rad51c as a human cancer susceptibility gene
10/13/2011	WO2011124708A1 Method for precipitating anionic surfactant ions in the presence of nucleic acids
10/13/2011	WO2011124684A1 Method for detecting specific nucleic acid sequences
10/13/2011	WO2011124669A1 Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family
10/13/2011	WO2011124652A1 Immunodominant peptide of polyomavirus jc and uses thereof
10/13/2011	WO2011123945A1 Compostions, methods and uses for treating respiratory syncytial virus infection
10/13/2011	WO2011095888A3 Method and rapid test device for detection of target molecule
10/13/2011	WO2011088391A3 Predicting and reducing alloimmunogenicity of protein therapeutics
10/13/2011	WO2011086189A3 Constructs, vectors and cyanobacteria for the synthesis of fatty alcohols, and methods for producing fatty alcohols in cyanobacteria
10/13/2011	WO2011081869A3 Method and materials for separating nucleic acid materials
10/13/2011	WO2011071343A3 Heterodimer core-shell nanoparticle in which raman-active molecules are located at a binding portion of a nanoparticle heterodimer, use thereof, and method for preparing same
10/13/2011	WO2011069029A3 Lateral flow assays
10/13/2011	WO2011068546A3 Prognosis, diagnosis and identification of multiple myeloma based on global gene expression profiling
10/13/2011	WO2011067758A3 Immunogenic fragments and multimers from streptococcus pneumoniae proteins
10/13/2011	WO2011063210A3 Methods of mapping genomic methylation patterns
10/13/2011	WO2011052906A3 Use of eif3m for the diagnosis and treatment of cancer
10/13/2011	WO2011049343A3 Methods and kits for the k-ras mutant detection using pna mediated real-tim pcr clamping
10/13/2011	WO2011049312A3 High throughput oligonucleotide synthesizer
10/13/2011	WO2010103284A8 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene
10/13/2011	US20110252510 Soybean Plant and Seed Corresponding to Transgenic Event MON87754 and Methods for Detection Thereof
10/13/2011	US20110252509 Method for Producing a Transgenic Cell with Increased Gamma-Aminobutyric Acid (Gaba) Content
10/13/2011	US20110252501 Transgenic plants with enhanced agronomic traits
10/13/2011	US20110252499 Compositions related to the quantitative trait locus 6 (qtl6) in maize and methods of use
10/13/2011	US20110252489 Method of identifying prolificacy in mammals
10/13/2011	US20110252488 Method of Identifying Genes which Promote Hybrid Vigour and Hybrid Debility and Uses Thereof
10/13/2011	US20110251983 Methods for the survey and genetic analysis of populations
10/13/2011	US20110251376 Mammalian Tumor Susceptibility Genes and their Uses
10/13/2011	US20110251272 Methods and compositions for predicting drug responses
10/13/2011	US20110251256 Use of trim72 as a target for muscle and heart enhancer
10/13/2011	US20110251252 Biomarkers for mdm2 inhibitors for use in treating disease
10/13/2011	US20110251246 Small molecule inhibitors of muc1 and methods of identifying the same
10/13/2011	US20110251195 Adrb2 gene polymorphism associated with intraocular pressure response to topical beta-blockers
10/13/2011	US20110251156 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
10/13/2011	US20110251135 Inhibitors of peritoneal seeding of cancer cells
10/13/2011	US20110251109 Fluidic methods for devices for parallel chemical reactions
10/13/2011	US20110251107 G-quadruplex binding assays and compounds therefor
10/13/2011	US20110251106 Pvii phage display
10/13/2011	US20110251105 Methods for detecting target analytes and enzymatic reactions
10/13/2011	US20110251104 Compositions and methods for detecting deacetylase activity
10/13/2011	US20110251101 Combinatorial decoding of random nucleic acid arrays
10/13/2011	US20110251099 SERUM MARKERS PREDICTING CLINICAL RESPONSE TO ANTI-TNFa ANTIBODIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
10/13/2011	US20110251097 Diagnostic kit of colon cancer using colon cancer related marker and diagnostic method thereof
10/13/2011	US20110251095 Mara family helix-turn-helix domains and their methods of use
10/13/2011	US20110251094 Biomarkers for hypertensive disorders of pregnancy
10/13/2011	US20110251091 Thyroid tumors identified
10/13/2011	US20110251090 Pancreatic cancer related gene ttll4
10/13/2011	US20110251087 Prognostic and diagnostic method for cancer therapy
10/13/2011	US20110251086 Neuroblastoma prognostic multigene expression signature
10/13/2011	US20110251084 System for the Detection of a Biological Pathogen and Use Thereof
10/13/2011	US20110251083 Multiplexed Amplification of Short Nucleic Acids
10/13/2011	US20110251081 Methods and compositions for determining gene function
10/13/2011	US20110251080 Sample processing apparatus and method
10/13/2011	US20110251077 Methods and Systems for Diagnosis of Non-Central Nervous System (CNS) Diseases in CNS Samples
10/13/2011	US20110251076 Non-invasive detection of fetal genetic traits
10/13/2011	US20110251073 Compositions And Methods Comprising Variant Microbial Proteases
10/13/2011	US20110250703 Il1rl-1 as a cardiovascular disease marker and therapeutic target
10/13/2011	US20110250693 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/13/2011	US20110250669 Method and apparatus for selectively targeting specific cells within a cell population
10/13/2011	US20110250633 Device and Method for Automatically Analyzing Micro Organisms in a Sample
10/13/2011	US20110250632 Methods for conducting cellular assays
10/13/2011	US20110250631 Proteoglycan degrading mutants for treatment of cns
10/13/2011	US20110250630 Motif-grafted hybrid polypeptides and uses thereof
10/13/2011	US20110250629 Alcohol production process
10/13/2011	US20110250628 Hcv replicons containing ns5b from genotype 2b
10/13/2011	US20110250627 Methods for assaying percentage of glycated hemoglobin
10/13/2011	US20110250626 Visual Assays for Coatings Incorporating Bioactive Enzymes for Catalytic Functions
10/13/2011	US20110250622 Method for diagnosing auto-immune chronic urticaria
10/13/2011	US20110250621 Method for in vitro assay of the circulating tissue factor, and use in the detection of coagulation diseases
10/13/2011	US20110250614 Methods and compositions for detecting the activation state of multiple proteins in single cells
10/13/2011	US20110250612 Novel centromeric protein shugoshin
10/13/2011	US20110250611 Immunoglobulin display vectors
10/13/2011	US20110250610 Fermentive production of isobutanol using highly active ketol-acid reductoisomerase enzymes
10/13/2011	US20110250609 Methods For The Detection, Analysis And Isolation Of Nascent Proteins
10/13/2011	US20110250608 Use of ultraconserved rna in detection and treatment of cancer
10/13/2011	US20110250607 Yeast-based methods of identifying nucleic acids and compounds for treating neurodegenerative diseases
10/13/2011	US20110250606 Method for the identification of carcinogenic compounds
10/13/2011	US20110250605 Genotyping hla loci
10/13/2011	US20110250604 Methods of detecting sources of microorganism contamination
10/13/2011	US20110250603 Methods for Sequencing Individual Nucleic Acids Under Tension
10/13/2011	US20110250602 Methods and Computer Software Products for Identifying Transcribed Regions of a Genome
10/13/2011	US20110250601 Bisulfite Conversion of DNA
10/13/2011	US20110250600 Marker for cancer prognosis and methods related thereto
10/13/2011	US20110250599 Methods and Compositions to Detect Nucleic Acids in a Biological Sample
10/13/2011	US20110250598 Detergent free polymerases
10/13/2011	US20110250597 Digital analyte analysis
10/13/2011	US20110250596 Methods, kits and compositions pertaining to linear beacons
10/13/2011	US20110250595 Analysis of single nucleotide polymorphisms using end labeling
10/13/2011	US20110250594 Methods for genetic analysis of textiles made of gossypium barbadense and gossypium hirsutum cotton
10/13/2011	US20110250593 Testing lumenectomy samples for markers of non-vascular diseases
10/13/2011	US20110250592 Methods for determining a patient's susceptibility of contracting a nosocomial infection and for establishing a prognosis of the progression of septic syndrome
10/13/2011	US20110250591 METHOD OF DESIGNING siRNAS FOR GENE SILENCING
10/13/2011	US20110250590 Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
10/13/2011	US20110250589 Biomarkers for lung disease monitoring
10/13/2011	US20110250588 Method for detecting cancer cells in blood sample

1 ... 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 ... 3003